Drug profile · INN
anamorelin
ADLUMIZ
anamorelin (ADLUMIZ) is a ghrelin receptor agonist.
EMA: refused Various (V03) V03
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — anamorelin
- Class
- Various (V03)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
anamorelin (ADLUMIZ) is a ghrelin receptor agonist.
Key facts
INN anamorelin
Brand ADLUMIZ
Mechanism Ghrelin receptor agonist
Therapeutic class Various (V03)
ATC code V03
Mechanism of action
Ghrelin receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | refused | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is anamorelin?
anamorelin (ADLUMIZ) is a ghrelin receptor agonist.
What is the brand name for anamorelin?
ADLUMIZ is a marketed brand name for anamorelin. Check FDA Drugs@FDA for the current US label holder and prescribing information.